Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

GREY:IMVIF - Post Discussion

IMV Inc > Capitalize on DPX platform in 2022
View:
Post by Biotech010 on Mar 17, 2022 8:56am

Capitalize on DPX platform in 2022

On the webcast, which was great with lots of new info, the CEO mentioned right in the beginning, that IMV is going to capitalize on the DPX platform in 2022!

 

This is the first time that the CEO was loud and clear....deals are coming!

Comment by Biotech010 on Mar 20, 2022 5:02pm
Very strong close last friday on good volume. Thew technical picture looks bright. But more important, we finally have management that can sell the platform. They mentioned using other platform deals as a reference. So this presentation was all about DPX and we can expect a lot of news coming in 2022 from it. "So it's a very versatile platform. And as Andrew mentioned before, that ...more  
Comment by Biotech010 on Mar 20, 2022 5:09pm
take a few minutes to read this: https://seekingalpha.com/article/4496254-imv-inc-imv-ceo-andrew-hall-on-q4-2021-results-earnings-call-transcript
IMV Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities